W. L. Gore & Associates Acquires Premier Bioactive Heparin Technology Company.FLAGSTAFF Flagstaff, city (1990 pop. 45,857), seat of Coconino co., N Ariz., near the San Francisco Peaks; inc. 1894. Lumbering, ranching, and a lively tourist trade thrive in the region, where many ruined pueblos, numerous state parks, several lakes, and large pine forests , Ariz. -- W. L. Gore & Associates Inc. (Gore) announced today that it has acquired Carmeda AB, a Sweden-based manufacturer of the most clinically proven, hemocompatible surface coating Surface coating A substance applied to other materials to change the surface properties, such as color, gloss, resistance to wear or chemical attack, or permeability, without changing the bulk properties. for medical devices. Carmeda has been a strategic supplier to Gore of heparin and heparin-related technologies for nearly 10 years. Financial details and other terms of the agreement are confidential. The Carmeda AB leadership team and work force will remain in its existing facility in Upplands Vasby, Sweden. The Carmeda(R) BioActive bi·o·ac·tive adj. Of or relating to a substance that has an effect on living tissue. bioactive having an effect on or eliciting a response from living tissue. Surface (CBAS CBAS Command Budget Automated System CBAS Computrols Building Automation System (building automation software) CBAS Computerized Building Automation System CBAS Corporate Business Applications Support (R)) mimics the non-thrombogenic properties of the endothelial endothelial /en·do·the·li·al/ (-the´le-al) pertaining to or made up of endothelium. Endothelial A layer of cells that lines the inside of certain body cavities, for example, blood vessels. lining of blood vessels Blood vessels Tubular channels for blood transport, of which there are three principal types: arteries, capillaries, and veins. Only the larger arteries and veins in the body bear distinct names. using a patented "end-point attachment" covalent bonding of heparin. No other biologically active coating demonstrates the well-documented long-term bioactivity bi·o·ac·tiv·i·ty n. The effect of a given agent, such as a vaccine, upon a living organism or on living tissue. of CBAS. The unique CBAS chemistry enables the immobilized heparin on the device surface to reduce thrombogenicity Thrombogenicity refers to the tendency of a material in contact with the blood to produce a thrombus, or clot. It not only refers to fixed thrombi but also to emboli, thrombi which have become detached and travel through the bloodstream. . Thus, CBAS expresses stable, antithrombotic activity and avoids the "dosing" resulting from the leaching heparin technologies. Gore utilizes the CBAS coating in its GORE-TEX(R) PROPATEN Vascular Graft. The CBAS coating provides unique hemocompatibility by minimizing clot formation on the inside surface of GORE-TEX PROPATEN Vascular Grafts. Such clots can result in blockages that can reduce blood flow through the grafts and may require clinical intervention. The GORE-TEX PROPATEN Vascular Graft is commercially available to physicians in Europe and elsewhere outside the United States. It is an investigational device in the United States, limited by U.S. law to investigational use only. A U.S. clinical study under a Food & Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) IDE is currently in progress. John Sininger, leader of the Gore Medical Products Division, stated, "At the heart of Gore's interest in Carmeda is our comprehensive strategy for growing our business and expanding offerings in the medical products marketplace. Part of that strategy involves strategic acquisitions of companies that share our commitment to applying product technologies that make a difference in the lives of patients. Carmeda is just such a company." "We are very excited at the prospects for the winning combination of two premier biomedical technologies, bioactive heparin and ePTFE, for improving medical device performance and positively impacting patients' lives," said Paul Begovac, Ph.D., technology leader at Gore. "We are confident that, together with Carmeda, we can continue to offer our customers the finest and most innovative cardiovascular products." About Gore & Associates The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for three decades. During that time, more than 13 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair Hernia Repair Definition Hernia repair is a surgical procedure to return an organ that protrudes through a weak area of muscle to its original position. and sutures for use in vascular, cardiac, general surgery and orthopedic procedures. Gore was recently named the second best company to work for by Fortune Magazine. The company's Medical Products Division is celebrating its 30-year anniversary worldwide throughout 2005. Products listed may not be available in all markets pending regulatory clearance. GORE, GORE-TEX(R) and PROPATEN are trademarks of W. L. Gore & Associates Inc. Carmeda(R) BioActive Surface and CBAS(R) are trademarks of Carmeda AB. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion